APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Modulators

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GABA Receptor Modulators Market Outlook and Growth Opportunities 2026

20 December 2025211 pages

Choose your research edition.

Industry ResearchGABA Receptor Modulators Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Modulators Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal GABA Receptor Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Modulators Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Modulators Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global GABA Receptor Modulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GABA Receptor Modulators market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GABA Receptor Modulators market include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sanofi, Novartis, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GABA Receptor Modulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GABA Receptor Modulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABA Receptor Modulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA Receptor Modulators market size, projected growth trends, production technologies, key applications, and end-use industries.

GABA Receptor Modulators Segment by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

Sandoz

SAGE Therapeutics

Neurelis

Jazz Pharmaceuicals

Hikma

CHEPLAPHARM

Apotex

Akorn

GABA Receptor Modulators Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

GABA Receptor Modulators Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABA Receptor Modulators Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global GABA Receptor Modulators status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GABA Receptor Modulators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GABA Receptor Modulators significant trends, drivers, influence factors in global and regions.

6. To analyze GABA Receptor Modulators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABA Receptor Modulators market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GABA Receptor Modulators industry.

Chapter 3: Detailed analysis of GABA Receptor Modulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GABA Receptor Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GABA Receptor Modulators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GABA Receptor Modulators Industry Trends Table 2. GABA Receptor Modulators Industry Drivers Table 3. GABA Receptor Modulators Industry Opportunities and Challenges Table 4. GABA Receptor Modulators Industry Restraints Table 5. Global GABA Receptor Modulators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GABA Receptor Modulators Revenue Share by Company (2021-2026) Table 7. Global GABA Receptor Modulators Sales Volume by Company (K Units) & (2021-2026) Table 8. Global GABA Receptor Modulators Sales Volume Share by Company (2021-2026) Table 9. Global GABA Receptor Modulators Average Price (US$/Unit) of Company (2021-2026) Table 10. Global GABA Receptor Modulators Company Ranking, (2024-2026) & (USD Million) Table 11. Global GABA Receptor Modulators Key Company Manufacturing Base & Headquarters Table 12. Global GABA Receptor Modulators Company, Product Type & Application Table 13. Global GABA Receptor Modulators Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GABA Receptor Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of GABAA Receptors Table 18. Significant Companies of GABAB Receptors Table 19. Significant Companies of GABAC Receptors Table 20. Global GABA Receptor Modulators Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global GABA Receptor Modulators Sales Volume by Type (2021-2026) & (K Units) Table 22. Global GABA Receptor Modulators Sales Volume by Type (2027-2032) & (K Units) Table 23. Global GABA Receptor Modulators Sales Volume Share by Type (2021-2026) Table 24. Global GABA Receptor Modulators Sales Volume Share by Type (2027-2032) Table 25. Global GABA Receptor Modulators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global GABA Receptor Modulators Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global GABA Receptor Modulators Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global GABA Receptor Modulators Sales Value Share by Type (2021-2026) Table 29. Global GABA Receptor Modulators Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Epilepsy Table 31. Significant Companies of Anxiety Table 32. Significant Companies of Neuropathic Pain Table 33. Significant Companies of Insomnia Table 34. Significant Companies of Other Table 35. Global GABA Receptor Modulators Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global GABA Receptor Modulators Sales Volume by Application (2021-2026) & (K Units) Table 37. Global GABA Receptor Modulators Sales Volume by Application (2027-2032) & (K Units) Table 38. Global GABA Receptor Modulators Sales Volume Share by Application (2021-2026) Table 39. Global GABA Receptor Modulators Sales Volume Share by Application (2027-2032) Table 40. Global GABA Receptor Modulators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global GABA Receptor Modulators Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global GABA Receptor Modulators Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global GABA Receptor Modulators Sales Value Share by Application (2021-2026) Table 44. Global GABA Receptor Modulators Sales Value Share by Application (2027-2032) Table 45. Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global GABA Receptor Modulators Sales by Region (2021-2026) & (K Units) Table 47. Global GABA Receptor Modulators Sales Market Share by Region (2021-2026) Table 48. Global GABA Receptor Modulators Sales by Region (2027-2032) & (K Units) Table 49. Global GABA Receptor Modulators Sales Market Share by Region (2027-2032) Table 50. Global GABA Receptor Modulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global GABA Receptor Modulators Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global GABA Receptor Modulators Sales Value Share by Region (2021-2026) Table 53. Global GABA Receptor Modulators Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global GABA Receptor Modulators Sales Value Share by Region (2027-2032) Table 55. Global GABA Receptor Modulators Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global GABA Receptor Modulators Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global GABA Receptor Modulators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 60. Global GABA Receptor Modulators Sales Market Share by Country (2021-2026) Table 61. Global GABA Receptor Modulators Sales by Country (2027-2032) & (K Units) Table 62. Global GABA Receptor Modulators Sales Market Share by Country (2027-2032) Table 63. Global GABA Receptor Modulators Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global GABA Receptor Modulators Sales Value Market Share by Country (2021-2026) Table 65. Global GABA Receptor Modulators Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global GABA Receptor Modulators Sales Value Market Share by Country (2027-2032) Table 67. Takeda Company Information Table 68. Takeda Business Overview Table 69. Takeda GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Takeda GABA Receptor Modulators Product Portfolio Table 71. Takeda Recent Development Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva GABA Receptor Modulators Product Portfolio Table 76. Teva Recent Development Table 77. Sun Pharma Company Information Table 78. Sun Pharma Business Overview Table 79. Sun Pharma GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sun Pharma GABA Receptor Modulators Product Portfolio Table 81. Sun Pharma Recent Development Table 82. Shanghai Pharmaceuticals Holding Company Information Table 83. Shanghai Pharmaceuticals Holding Business Overview Table 84. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio Table 86. Shanghai Pharmaceuticals Holding Recent Development Table 87. Sanofi Company Information Table 88. Sanofi Business Overview Table 89. Sanofi GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sanofi GABA Receptor Modulators Product Portfolio Table 91. Sanofi Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novartis GABA Receptor Modulators Product Portfolio Table 96. Novartis Recent Development Table 97. Mylan Company Information Table 98. Mylan Business Overview Table 99. Mylan GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Mylan GABA Receptor Modulators Product Portfolio Table 101. Mylan Recent Development Table 102. Roche Company Information Table 103. Roche Business Overview Table 104. Roche GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Roche GABA Receptor Modulators Product Portfolio Table 106. Roche Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer GABA Receptor Modulators Product Portfolio Table 111. Pfizer Recent Development Table 112. Huazhong Pharmaceutical Company Information Table 113. Huazhong Pharmaceutical Business Overview Table 114. Huazhong Pharmaceutical GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio Table 116. Huazhong Pharmaceutical Recent Development Table 117. Sichuan HaiscoPharmaceuical Company Information Table 118. Sichuan HaiscoPharmaceuical Business Overview Table 119. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio Table 121. Sichuan HaiscoPharmaceuical Recent Development Table 122. GSK Company Information Table 123. GSK Business Overview Table 124. GSK GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GSK GABA Receptor Modulators Product Portfolio Table 126. GSK Recent Development Table 127. Fresenius Kabi Company Information Table 128. Fresenius Kabi Business Overview Table 129. Fresenius Kabi GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Fresenius Kabi GABA Receptor Modulators Product Portfolio Table 131. Fresenius Kabi Recent Development Table 132. Changzhou Siyao Pharmaceutical Company Information Table 133. Changzhou Siyao Pharmaceutical Business Overview Table 134. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio Table 136. Changzhou Siyao Pharmaceutical Recent Development Table 137. AstraZeneca Company Information Table 138. AstraZeneca Business Overview Table 139. AstraZeneca GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. AstraZeneca GABA Receptor Modulators Product Portfolio Table 141. AstraZeneca Recent Development Table 142. WG Critical Care Company Information Table 143. WG Critical Care Business Overview Table 144. WG Critical Care GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. WG Critical Care GABA Receptor Modulators Product Portfolio Table 146. WG Critical Care Recent Development Table 147. Viatris Company Information Table 148. Viatris Business Overview Table 149. Viatris GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Viatris GABA Receptor Modulators Product Portfolio Table 151. Viatris Recent Development Table 152. Torrent Pharma Company Information Table 153. Torrent Pharma Business Overview Table 154. Torrent Pharma GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Torrent Pharma GABA Receptor Modulators Product Portfolio Table 156. Torrent Pharma Recent Development Table 157. Sandoz Company Information Table 158. Sandoz Business Overview Table 159. Sandoz GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Sandoz GABA Receptor Modulators Product Portfolio Table 161. Sandoz Recent Development Table 162. SAGE Therapeutics Company Information Table 163. SAGE Therapeutics Business Overview Table 164. SAGE Therapeutics GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. SAGE Therapeutics GABA Receptor Modulators Product Portfolio Table 166. SAGE Therapeutics Recent Development Table 167. Neurelis Company Information Table 168. Neurelis Business Overview Table 169. Neurelis GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Neurelis GABA Receptor Modulators Product Portfolio Table 171. Neurelis Recent Development Table 172. Jazz Pharmaceuicals Company Information Table 173. Jazz Pharmaceuicals Business Overview Table 174. Jazz Pharmaceuicals GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio Table 176. Jazz Pharmaceuicals Recent Development Table 177. Hikma Company Information Table 178. Hikma Business Overview Table 179. Hikma GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Hikma GABA Receptor Modulators Product Portfolio Table 181. Hikma Recent Development Table 182. CHEPLAPHARM Company Information Table 183. CHEPLAPHARM Business Overview Table 184. CHEPLAPHARM GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. CHEPLAPHARM GABA Receptor Modulators Product Portfolio Table 186. CHEPLAPHARM Recent Development Table 187. Apotex Company Information Table 188. Apotex Business Overview Table 189. Apotex GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. Apotex GABA Receptor Modulators Product Portfolio Table 191. Apotex Recent Development Table 192. Akorn Company Information Table 193. Akorn Business Overview Table 194. Akorn GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Akorn GABA Receptor Modulators Product Portfolio Table 196. Akorn Recent Development Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. GABA Receptor Modulators Distributors List Table 200. GABA Receptor Modulators Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. GABA Receptor Modulators Product Image Figure 2. Global GABA Receptor Modulators Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Modulators Sales Value (2021-2032) & (US$ Million) Figure 4. Global GABA Receptor Modulators Sales (2021-2032) & (K Units) Figure 5. Global GABA Receptor Modulators Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global GABA Receptor Modulators Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. GABAA Receptors Image Figure 10. GABAB Receptors Image Figure 11. GABAC Receptors Image Figure 12. Global GABA Receptor Modulators Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global GABA Receptor Modulators Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global GABA Receptor Modulators Sales Volume Share by Type (2021-2032) Figure 15. Global GABA Receptor Modulators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global GABA Receptor Modulators Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global GABA Receptor Modulators Sales Value Share by Type (2021-2032) Figure 18. Epilepsy Image Figure 19. Anxiety Image Figure 20. Neuropathic Pain Image Figure 21. Insomnia Image Figure 22. Other Image Figure 23. Global GABA Receptor Modulators Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global GABA Receptor Modulators Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global GABA Receptor Modulators Sales Volume Share by Application (2021-2032) Figure 26. Global GABA Receptor Modulators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global GABA Receptor Modulators Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global GABA Receptor Modulators Sales Value Share by Application (2021-2032) Figure 29. Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global GABA Receptor Modulators Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global GABA Receptor Modulators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global GABA Receptor Modulators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America GABA Receptor Modulators Sales Value (2021-2032) & (US$ Million) Figure 34. North America GABA Receptor Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe GABA Receptor Modulators Sales Value (2021-2032) & (US$ Million) Figure 36. Europe GABA Receptor Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific GABA Receptor Modulators Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific GABA Receptor Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America GABA Receptor Modulators Sales Value (2021-2032) & (US$ Million) Figure 40. South America GABA Receptor Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa GABA Receptor Modulators Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa GABA Receptor Modulators Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt GABA Receptor Modulators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. GABA Receptor Modulators Value Chain Figure 128. Manufacturing Cost Structure Figure 129. GABA Receptor Modulators Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • Sandoz
  • SAGE Therapeutics
  • Neurelis
  • Jazz Pharmaceuicals
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABA Receptor Modulators Sales Value (2021-2032)
  4. 1.2.2 Global GABA Receptor Modulators Sales Volume (2021-2032)
  5. 1.2.3 Global GABA Receptor Modulators Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GABA Receptor Modulators Market Dynamics
  1. 2.1 GABA Receptor Modulators Industry Trends
  2. 2.2 GABA Receptor Modulators Industry Drivers
  3. 2.3 GABA Receptor Modulators Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Modulators Industry Restraints
3 GABA Receptor Modulators Market by Company
  1. 3.1 Global GABA Receptor Modulators Company Revenue Ranking in 2025
  2. 3.2 Global GABA Receptor Modulators Revenue by Company (2021-2026)
  3. 3.3 Global GABA Receptor Modulators Sales Volume by Company (2021-2026)
  4. 3.4 Global GABA Receptor Modulators Average Price by Company (2021-2026)
  5. 3.5 Global GABA Receptor Modulators Company Ranking (2024-2026)
  6. 3.6 Global GABA Receptor Modulators Company Manufacturing Base and Headquarters
  7. 3.7 Global GABA Receptor Modulators Company Product Type and Application
  8. 3.8 Global GABA Receptor Modulators Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GABA Receptor Modulators Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GABA Receptor Modulators Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GABA Receptor Modulators Market by Type
  1. 4.1 GABA Receptor Modulators Type Introduction
  2. 4.1.1 GABAA Receptors
  3. 4.1.2 GABAB Receptors
  4. 4.1.3 GABAC Receptors
  5. 4.2 Global GABA Receptor Modulators Sales Volume by Type
  6. 4.2.1 Global GABA Receptor Modulators Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GABA Receptor Modulators Sales Volume by Type (2021-2032)
  8. 4.2.3 Global GABA Receptor Modulators Sales Volume Share by Type (2021-2032)
  9. 4.3 Global GABA Receptor Modulators Sales Value by Type
  10. 4.3.1 Global GABA Receptor Modulators Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global GABA Receptor Modulators Sales Value by Type (2021-2032)
  12. 4.3.3 Global GABA Receptor Modulators Sales Value Share by Type (2021-2032)
5 GABA Receptor Modulators Market by Application
  1. 5.1 GABA Receptor Modulators Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Anxiety
  4. 5.1.3 Neuropathic Pain
  5. 5.1.4 Insomnia
  6. 5.1.5 Other
  7. 5.2 Global GABA Receptor Modulators Sales Volume by Application
  8. 5.2.1 Global GABA Receptor Modulators Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global GABA Receptor Modulators Sales Volume by Application (2021-2032)
  10. 5.2.3 Global GABA Receptor Modulators Sales Volume Share by Application (2021-2032)
  11. 5.3 Global GABA Receptor Modulators Sales Value by Application
  12. 5.3.1 Global GABA Receptor Modulators Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global GABA Receptor Modulators Sales Value by Application (2021-2032)
  14. 5.3.3 Global GABA Receptor Modulators Sales Value Share by Application (2021-2032)
6 GABA Receptor Modulators Regional Sales and Value Analysis
  1. 6.1 Global GABA Receptor Modulators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABA Receptor Modulators Sales by Region (2021-2032)
  3. 6.2.1 Global GABA Receptor Modulators Sales by Region: 2021-2026
  4. 6.2.2 Global GABA Receptor Modulators Sales by Region (2027-2032)
  5. 6.3 Global GABA Receptor Modulators Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GABA Receptor Modulators Sales Value by Region (2021-2032)
  7. 6.4.1 Global GABA Receptor Modulators Sales Value by Region: 2021-2026
  8. 6.4.2 Global GABA Receptor Modulators Sales Value by Region (2027-2032)
  9. 6.5 Global GABA Receptor Modulators Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GABA Receptor Modulators Sales Value (2021-2032)
  12. 6.6.2 North America GABA Receptor Modulators Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GABA Receptor Modulators Sales Value (2021-2032)
  15. 6.7.2 Europe GABA Receptor Modulators Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GABA Receptor Modulators Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GABA Receptor Modulators Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GABA Receptor Modulators Sales Value (2021-2032)
  21. 6.9.2 South America GABA Receptor Modulators Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GABA Receptor Modulators Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GABA Receptor Modulators Sales Value Share by Country, 2025 VS 2032
7 GABA Receptor Modulators Country-level Sales and Value Analysis
  1. 7.1 Global GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GABA Receptor Modulators Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GABA Receptor Modulators Sales by Country (2021-2032)
  4. 7.3.1 Global GABA Receptor Modulators Sales by Country (2021-2026)
  5. 7.3.2 Global GABA Receptor Modulators Sales by Country (2027-2032)
  6. 7.4 Global GABA Receptor Modulators Sales Value by Country (2021-2032)
  7. 7.4.1 Global GABA Receptor Modulators Sales Value by Country (2021-2026)
  8. 7.4.2 Global GABA Receptor Modulators Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GABA Receptor Modulators Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GABA Receptor Modulators Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GABA Receptor Modulators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda GABA Receptor Modulators Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva GABA Receptor Modulators Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharma
  14. 8.3.1 Sun Pharma Company Information
  15. 8.3.2 Sun Pharma Business Overview
  16. 8.3.3 Sun Pharma GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharma GABA Receptor Modulators Product Portfolio
  18. 8.3.5 Sun Pharma Recent Developments
  19. 8.4 Shanghai Pharmaceuticals Holding
  20. 8.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 8.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 8.4.3 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio
  24. 8.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi GABA Receptor Modulators Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Novartis GABA Receptor Modulators Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan GABA Receptor Modulators Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Roche GABA Receptor Modulators Product Portfolio
  48. 8.8.5 Roche Recent Developments
  49. 8.9 Pfizer
  50. 8.9.1 Pfizer Company Information
  51. 8.9.2 Pfizer Business Overview
  52. 8.9.3 Pfizer GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pfizer GABA Receptor Modulators Product Portfolio
  54. 8.9.5 Pfizer Recent Developments
  55. 8.10 Huazhong Pharmaceutical
  56. 8.10.1 Huazhong Pharmaceutical Company Information
  57. 8.10.2 Huazhong Pharmaceutical Business Overview
  58. 8.10.3 Huazhong Pharmaceutical GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio
  60. 8.10.5 Huazhong Pharmaceutical Recent Developments
  61. 8.11 Sichuan HaiscoPharmaceuical
  62. 8.11.1 Sichuan HaiscoPharmaceuical Company Information
  63. 8.11.2 Sichuan HaiscoPharmaceuical Business Overview
  64. 8.11.3 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio
  66. 8.11.5 Sichuan HaiscoPharmaceuical Recent Developments
  67. 8.12 GSK
  68. 8.12.1 GSK Company Information
  69. 8.12.2 GSK Business Overview
  70. 8.12.3 GSK GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 GSK GABA Receptor Modulators Product Portfolio
  72. 8.12.5 GSK Recent Developments
  73. 8.13 Fresenius Kabi
  74. 8.13.1 Fresenius Kabi Company Information
  75. 8.13.2 Fresenius Kabi Business Overview
  76. 8.13.3 Fresenius Kabi GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Fresenius Kabi GABA Receptor Modulators Product Portfolio
  78. 8.13.5 Fresenius Kabi Recent Developments
  79. 8.14 Changzhou Siyao Pharmaceutical
  80. 8.14.1 Changzhou Siyao Pharmaceutical Company Information
  81. 8.14.2 Changzhou Siyao Pharmaceutical Business Overview
  82. 8.14.3 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio
  84. 8.14.5 Changzhou Siyao Pharmaceutical Recent Developments
  85. 8.15 AstraZeneca
  86. 8.15.1 AstraZeneca Company Information
  87. 8.15.2 AstraZeneca Business Overview
  88. 8.15.3 AstraZeneca GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 AstraZeneca GABA Receptor Modulators Product Portfolio
  90. 8.15.5 AstraZeneca Recent Developments
  91. 8.16 WG Critical Care
  92. 8.16.1 WG Critical Care Company Information
  93. 8.16.2 WG Critical Care Business Overview
  94. 8.16.3 WG Critical Care GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 WG Critical Care GABA Receptor Modulators Product Portfolio
  96. 8.16.5 WG Critical Care Recent Developments
  97. 8.17 Viatris
  98. 8.17.1 Viatris Company Information
  99. 8.17.2 Viatris Business Overview
  100. 8.17.3 Viatris GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Viatris GABA Receptor Modulators Product Portfolio
  102. 8.17.5 Viatris Recent Developments
  103. 8.18 Torrent Pharma
  104. 8.18.1 Torrent Pharma Company Information
  105. 8.18.2 Torrent Pharma Business Overview
  106. 8.18.3 Torrent Pharma GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Torrent Pharma GABA Receptor Modulators Product Portfolio
  108. 8.18.5 Torrent Pharma Recent Developments
  109. 8.19 Sandoz
  110. 8.19.1 Sandoz Company Information
  111. 8.19.2 Sandoz Business Overview
  112. 8.19.3 Sandoz GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Sandoz GABA Receptor Modulators Product Portfolio
  114. 8.19.5 Sandoz Recent Developments
  115. 8.20 SAGE Therapeutics
  116. 8.20.1 SAGE Therapeutics Company Information
  117. 8.20.2 SAGE Therapeutics Business Overview
  118. 8.20.3 SAGE Therapeutics GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 SAGE Therapeutics GABA Receptor Modulators Product Portfolio
  120. 8.20.5 SAGE Therapeutics Recent Developments
  121. 8.21 Neurelis
  122. 8.21.1 Neurelis Company Information
  123. 8.21.2 Neurelis Business Overview
  124. 8.21.3 Neurelis GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Neurelis GABA Receptor Modulators Product Portfolio
  126. 8.21.5 Neurelis Recent Developments
  127. 8.22 Jazz Pharmaceuicals
  128. 8.22.1 Jazz Pharmaceuicals Company Information
  129. 8.22.2 Jazz Pharmaceuicals Business Overview
  130. 8.22.3 Jazz Pharmaceuicals GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio
  132. 8.22.5 Jazz Pharmaceuicals Recent Developments
  133. 8.23 Hikma
  134. 8.23.1 Hikma Company Information
  135. 8.23.2 Hikma Business Overview
  136. 8.23.3 Hikma GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Hikma GABA Receptor Modulators Product Portfolio
  138. 8.23.5 Hikma Recent Developments
  139. 8.24 CHEPLAPHARM
  140. 8.24.1 CHEPLAPHARM Company Information
  141. 8.24.2 CHEPLAPHARM Business Overview
  142. 8.24.3 CHEPLAPHARM GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 CHEPLAPHARM GABA Receptor Modulators Product Portfolio
  144. 8.24.5 CHEPLAPHARM Recent Developments
  145. 8.25 Apotex
  146. 8.25.1 Apotex Company Information
  147. 8.25.2 Apotex Business Overview
  148. 8.25.3 Apotex GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Apotex GABA Receptor Modulators Product Portfolio
  150. 8.25.5 Apotex Recent Developments
  151. 8.26 Akorn
  152. 8.26.1 Akorn Company Information
  153. 8.26.2 Akorn Business Overview
  154. 8.26.3 Akorn GABA Receptor Modulators Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Akorn GABA Receptor Modulators Product Portfolio
  156. 8.26.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABA Receptor Modulators Value Chain Analysis
  2. 9.1.1 GABA Receptor Modulators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABA Receptor Modulators Sales Mode & Process
  6. 9.2 GABA Receptor Modulators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABA Receptor Modulators Distributors
  9. 9.2.3 GABA Receptor Modulators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst